Self-Avoiding Gamma Peptide Nucleic Acids for Selective Targeting of RNA Secondary Structures
ACS Chemical Biology · 17.04.2026 · 21 (4) · 666-673
DOI: 10.1021/acschembio.5c00830 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Chemical Biology, online erschienen am 17.03.2026. Verfasst von Isha Dhami und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry and Institute for Biomolecular Design and Discovery (IBD), Carnegie Mellon University, 4400 Fifth Avenue, Pittsburgh, Pennsyl…. Hauptthemen laut MEDLINE: Peptide Nucleic Acids, RNA. Die Arbeit nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: DSF Charitable Foundation.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Chemistry and Institute for Biomolecular Design and Discovery (IBD), Carnegie Mellon University, 4400 Fifth Avenue, Pittsburgh, Pennsylvania 15213, United States.
ORCID-Profile: Isha Dhami, Shivaji A Thadke, Danith H Ly
Förderung
- DSF Charitable Foundation
Zitieren
APA
Dhami, I., Thadke, S. A., Perera, J. D. R., Batwal, R., Zheng, E., Thrikawala, S. W., Aryal, B., & Ly, D. H. (2026). Self-Avoiding Gamma Peptide Nucleic Acids for Selective Targeting of RNA Secondary Structures. ACS Chemical Biology, 21(4), 666-673. https://doi.org/10.1021/acschembio.5c00830
Vancouver
Dhami I, Thadke SA, Perera JDR, Batwal R, Zheng E, Thrikawala SW, et al. Self-Avoiding Gamma Peptide Nucleic Acids for Selective Targeting of RNA Secondary Structures. ACS Chemical Biology. 2026;21(4):666-673. doi:10.1021/acschembio.5c00830
BibTeX
@article{Dhami2026,
author = {Dhami, Isha and Thadke, Shivaji A and Perera, J Dinithi R and Batwal, Ramesh and Zheng, En and Thrikawala, Savani W and Aryal, Babita and Ly, Danith H},
title = {Self-Avoiding Gamma Peptide Nucleic Acids for Selective Targeting of RNA Secondary Structures},
journal = {ACS Chemical Biology},
year = {2026},
volume = {21},
number = {4},
pages = {666--673},
doi = {10.1021/acschembio.5c00830}
}
EUVIMED